{"entity":{"type":"insider","cik":"0001697779","url":"/insider/0001697779","json_url":"/insider/0001697779.json","name":"Ence Chuck","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2024-01-31","last":"2025-11-06","span_basis":"filed_date"},"name_variants":[{"name":"Ence Chuck","source":"filing","n_filings":3,"first_seen":"2024-01-31","last_seen":"2025-11-06"}],"transactions":[{"id":4491885,"accession":"0001213900-25-106838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-106838","line_url":"/filing/0001213900-25-106838#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001697779","owner_name":"Ence Chuck","owner_url":"/insider/0001697779","role":"Officer (CAO and COO)","officer_title":"CAO and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":136000.0,"shares_display":"136,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":299200.0,"total_display":"299,200.00","shares_owned_after":403931.0,"shares_owned_after_display":"403,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-06","scope":"insider"},{"id":5109020,"accession":"0001213900-25-046086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-046086","line_url":"/filing/0001213900-25-046086#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001697779","owner_name":"Ence Chuck","owner_url":"/insider/0001697779","role":"Officer (CA and CO)","officer_title":"CA and CO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228961.0,"shares_display":"228,961","price_per_share":0.4513,"price_display":"0.45","price_state":"stated","total_value":103330.0993,"total_display":"103,330.10","shares_owned_after":267931.0,"shares_owned_after_display":"267,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":2739294,"accession":"0001213900-24-008557","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-008557","line_url":"/filing/0001213900-24-008557#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001697779","owner_name":"Ence Chuck","owner_url":"/insider/0001697779","role":"Officer (CA and CO)","officer_title":"CA and CO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13670.0,"shares_display":"13,670","price_per_share":4.0548,"price_display":"4.05","price_state":"stated","total_value":55429.116,"total_display":"55,429.12","shares_owned_after":38970.0,"shares_owned_after_display":"38,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-01-31","scope":"insider"},{"id":2739290,"accession":"0001213900-24-008557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-008557","line_url":"/filing/0001213900-24-008557#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001697779","owner_name":"Ence Chuck","owner_url":"/insider/0001697779","role":"Officer (CA and CO)","officer_title":"CA and CO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14500.0,"shares_display":"14,500","price_per_share":3.8657,"price_display":"3.87","price_state":"stated","total_value":56052.65,"total_display":"56,052.65","shares_owned_after":25300.0,"shares_owned_after_display":"25,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider"},{"id":2739285,"accession":"0001213900-24-008557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-008557","line_url":"/filing/0001213900-24-008557#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001697779","owner_name":"Ence Chuck","owner_url":"/insider/0001697779","role":"Officer (CA and CO)","officer_title":"CA and CO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10800.0,"shares_display":"10,800","price_per_share":3.6517,"price_display":"3.65","price_state":"stated","total_value":39438.36,"total_display":"39,438.36","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001553643","name":"RELMADA THERAPEUTICS, INC.","url":"/issuer/0001553643","role":"Officer (CAO and COO)","n_filings":3,"first_seen":"2024-01-31","last_seen":"2025-11-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697779","retrieved_at":"2026-08-21T21:27:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}